MSU
DMK

Mizuho Securities USA’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

Mizuho Securities USA’s Portfolio DMK Stock Details DMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-1,889
Closed -$454K – 242
2016
Q3 		$454K Buy
+1,889
New +$393K 0.04% 152
2015
Q3 		– Sell
-297
Closed -$87K – 208
2015
Q2 		$87K Buy
+297
New +$89.7K 0.01% 173

Other funds holding DMK

SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
LCM
Leisure Capital Management Costa Mesa, California $286M AUM 26.75% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
SGS
Sterling Global Strategies Carlsbad, California $18M AUM 11.58% 1-Year Est. Return

Mizuho Securities USA's DMK Position: Q4 2016 in Review

Mizuho Securities USA sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q4 2016, closing a stake of 1,889 shares — an estimated $454K sold.

Mizuho Securities USA first reported a position in DMK in Q2 2015 and held it in 2 quarters. The position peaked at $454K in Q3 2016. 35 funds tracked by Wall St. Rank hold DMK as of Q4 2016.

  • Mizuho Securities USA reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q4 2016 after selling out during the quarter.
  • Mizuho Securities USA sold 1,889 DMK Pharmaceuticals Corporation Common Stock shares in Q4 2016, an estimated $454K.
  • Mizuho Securities USA first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q2 2015 and held it in 2 quarters.
  • Mizuho Securities USA's DMK Pharmaceuticals Corporation Common Stock position peaked at $454K in Q3 2016.
  • 35 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q4 2016.

Based on Mizuho Securities USA's 13F filing for Q4 2016, filed 7 Feb 2017.